Atea Pharmaceuticals Inc (AVIR)

Total Costs & Expenses

$183.61M

TTM · Period ending: · USD

AVIR logo

AVIR Total Costs & Expenses

Latest reported$183.61M
AVIR TTM Total Costs & Expenses ($14.61M → $183.61M)
High-resolution chart · PNG

AVIR total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Atea Pharmaceuticals Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
183,608,000
189,854,000
180,887,000
164,979,000
156,614,000
162,185,000
192,950,000
200,497,000
204,080,000
192,399,000
164,162,000
157,488,000
132,984,000
130,044,000
130,650,000
161,750,000
200,427,000
219,836,000
212,991,000
169,978,000
132,649,000
90,948,000
59,663,000
36,426,000
22,566,000
16,281,000
14,608,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.